Innovations in Vaccine Development against Malaria: Prospects for East Africa

Tugonza Akiro F.

Faculty of Science and Technology Kampala International University Uganda

ABSTRACT

Malaria remains a significant public health challenge in East Africa, disproportionately affecting vulnerable populations such as children under five and pregnant women. Despite advancements in vector control, diagnostic tools, and antimalarial therapies, the region faces persistent challenges, including insecticide and drug resistance, logistical barriers, and asymptomatic carriers. Vaccines represent a promising solution to complement existing interventions and disrupt the malaria transmission cycle. This review explores recent innovations in malaria vaccine development, including the RTS,S/AS01 vaccine, multi-antigen approaches, mRNA platforms, transmission-blocking vaccines (TBVs), and viral vector vaccines. Additionally, it examines the unique epidemiological, infrastructural, and socioeconomic barriers to vaccine deployment in East Africa, while highlighting opportunities for integrating vaccines into existing malaria control programs. The review emphasizes the importance of regional collaborations, policy support, and sustainable funding to enhance vaccine accessibility and effectiveness. By leveraging technological advancements and addressing systemic challenges, East Africa has the potential to significantly reduce its malaria burden and progress toward elimination.

Keywords: Malaria, Vaccine Development, Transmission-Blocking Vaccines (TBVs), East Africa, Epidemiological Challenges

CITE AS: Tugonza Akiro F. (2025). Innovations in Vaccine Development against Malaria: Prospects for East Africa. INOSR Scientific Research 12(1):6-11. https://doi.org/10.59298/INOSRSR/2025/12.1.61100